Forecasting Art Coverage in Kenya Using the Multilayer Perceptron Neural Network

Abstract

In this research article, the ANN approach was applied to analyze ART coverage in Kenya. The employed annual data covers the period 2000-2018 and the out-of-sample period ranges over the period 2019-2023. The residuals and forecast evaluation criteria (Error, MSE and MAE) of the applied model indicate that the model is stable in forecasting ART coverage in Kenya. The ANN (9,12,1) model projections suggests that the country is likely record a decline in ART coverage over the period 2019-2023. Therefore the government is encouraged to intensify demand creation for HIV testing and ART services and allocate more resources to TB/HIV program collaboration amongst other strategies.

Country : Zimbabwe

1 Dr. Smartson. P. NYONI2 Thabani NYONI

  1. ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
  2. Department of Economics, University of Zimbabwe, Harare, Zimbabwe

IRJIET, Volume 5, Issue 3, March 2021 pp. 161-165

doi.org/10.47001/IRJIET/2021.503028

References

  1. Cleary S, Silal S, Birch S, Carrara H, Pillay-van Wyk V, Rehle T, et al. Equity in the use of antiretroviral treatment in the public health care system in urban South Africa. Health Policy. 99: 261–266. https:// doi.org/10.1016/j.healthpol.2010.10.016 PMID: 21075470.
  2. Fojnica, A., Osmanoviae & Badnjeviae A (2016). Dynamic model of tuberculosis-multiple strain prediction based on artificial neural network. In proceedings of the 2016 5th Mediterranean conference on embedded computing pp290-293.
  3. Kaushik AC &Sahi. S (2018). Artificial neural network-based model for orphan GPCRs.Neural.Comput.Appl. 29,985-992.
  4. Loubiere S, Boyer S, Protopopescu C, Bonono CR, Abega SC, Spire B, et al. Decentralization of HIV care in Cameroon: Increased access to antiretroviral treatment and associated persistent barriers. Health Policy. 2009; https://doi.org/10.1016/j.healthpol.2009.03.006 PMID: 19371960.
  5. Makwiza I, Nyirenda L, Bongololo G, Banda T, Chimzizi R, Theobald S. Who has access to counseling and testing and anti-retroviral therapy in Malawi—An equity analysis. Int J Equity Health. 2009; https:// doi.org/10.1186/1475-9276-8-13 PMID: 19416512.
  6. MOH Kenya (2015) National Plan for Accelerating HIV Care and Treatment 2015-2017.
  7. MOH. Kenya HIV Estimates. 2014
  8. Mooney AC, Gottert A, Khoza N, Rebombo D, Hove J, Sua ´rez AJ, et al. Men’s perceptions of treatment as prevention in South Africa: Implications for engagement in HIV care and treatment. AIDS Educ Prev. 2017; https://doi.org/10.1521/aeap.2017.29.3.274 PMID: 28650225.
  9. Tromp N, Michels C, Mikkelsen E, Hontelez J, Baltussen R. Equity in utilization of antiretroviral therapy for HIV-infected people in South Africa: a systematic review. Int J Equity Health. 2014; 13: 60. https:// doi.org/10.1186/s12939-014-0060-z PMID: 25078612.
  10. W. Young1*, Andrea A. Kim1, Joyce Wamicwe2, Lilly Nyagah2, Catherine Kiama3, John Stover4, Johansen Oduor5, Emily A. Rogena6, Edwin Walong6, Emily ZielinskiGutierrez1, Andrew Imbwaga7, Martin Sirengo2, Timothy A. Kellogg8, Kevin M. De Cock1HIV-associated mortality in the era of antiretroviral therapy scale-up – Nairobi, Kenya, 2015PLOS ONE | https://doi.org/10.1371/journal.pone.0181837 August 2, 2017 1 / 10.
  11. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV [Internet]. Geneva, Switzerland: WHO; 2015 Sep. http://apps.who.int/iris/bitstream/ 10665/186275/1/9789241509565_eng.pdf.
  12. Yan C Q., Wang R B., Liu C H., Jiang Y (2019). Application of ARIMA model in predicting the incidence of tuberculosis in China from 2018-2019.Zhonghua 40(6):633-637.
  13. Zhang G P, “Time series forecasting using a hybrid ARIMA and neural network model”, Neurocomputing 50: 159–175.